Curis Inc (CRIS)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

128 SPRING STREET LEXINGTON, MA 02421

Functions as a therapeutic drug development company. Focuses on regulatory signaling pathways that control the repair and regeneration of human tissue and organs.

Data as of 2021-05-08 10:39:09 -0400
Market Cap938.07 Million Shares Outstanding91.519 Million Avg 30-day Volume1.543 Million
P/E Ratio-31.3652 Dividend Yield EPS-0.615
Price/Sales86.58 Debt to Equity1.56 EBITDA-24.754 Million
Price to Book Value7.18 Forward PE-26.83 Enterprise Value770.467 Million
Total Cash168.494 Million Current Debt10.079 Million Gross Profit10.301 Million
BETA0.0 52-week High/Low13.44 / 0.72 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CRIS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 0 2 (0.12%) 0 (0.0%)
Funds Holding: 95 53 79.25% 42 (2.52%) 21 (1.31%) 100.0%
13F shares: 63.342 Million 20.458 Million 209.62% 49.778 Million 16.175 Million 207.75%
% Ownership 71.7212 34.7818 106.2% 56.3631 27.5007 104.95%
New Positions: 50 12 316.67% 26 7 271.43%
Increased Positions 27 16 68.75% 9 6 50.0%
Closed Positions 8 7 14.29% 5 2 150.0%
Reduced Positions 13 9 44.44% 6 3 100.0%
Total Calls 1.625 Million 93.969 Thousand 1628.82% 761.233 Thousand 19.131 Thousand 3879.05%
Total Puts 391.748 Thousand 13.082 Thousand 2894.56% 44.1 Thousand
PUT/CALL Ratio 0.24 0.14 71.43% 0.06 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRIS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRIS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARTELL ROBERT HEAD OF RESEARCH & DEVELOPMENT

  • Officer
0 2021-01-28 1

GREENACRE MARTYN D

  • Director
0 2021-01-28 1

RUBIN MARC

  • Director
0 2021-01-28 1

KAITIN KENNETH I

  • Director
0 2021-01-28 1

DENTZER JAMES E PRESIDENT & CEO

  • Officer
  • Director
0 2021-01-28 2

KUNKEL LORI ANNE

  • Director
0 2021-01-28 1

STEINKRAUSS WILLIAM CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-28 1

NOEL MARK VICE-PRESIDENT

  • Officer
0 2020-02-02 0

FATTAEY ALI PH.D. PRESIDENT & CEO

  • Officer
  • Director
0 2018-05-15 0

TUCK DAVID CHIEF MEDICAL OFFICER

  • Officer
0 2018-05-15 0

MCNAB JAMES R

  • Director
929,688 2017-05-03 0

PIENTA KENNETH

  • Director
0 2017-02-28 0

MOHINDRU MANI CHIEF STRATEGY OFFICER

  • Officer
0 2017-02-14 0

PASSERI DANIEL R

  • Director
0 2016-01-19 0

GRAY MICHAEL CFO

  • Officer
0 2015-05-27 0

VINER JAYE CHIEF MEDICAL OFFICER

  • Officer
0 2015-05-27 0

TOBIN JAMES R

  • Director
0 2015-01-26 0

AURIGENE DISCOVERY TECHNOLOGIES LTD

DR REDDYS LABORATORIES LTD

  • 10% Owner
17,120,131 2015-01-18 0

AURIGENE DISCOVERY TECHNOLOGIES LTD

DR REDDYS LABORATORIES LTD

DR. REDDY'S HOLDINGS LTD

  • 10% Owner
27,328,464 2015-01-18 0

VOI MAURIZIO CHIEF MEDICAL OFFICER

  • Officer
0 2013-01-17 0

BAYH SUSAN B

  • Director
0 2013-01-17 0

QIAN CHANGGENG VP, RESEARCH & PRECLINICAL DEV

  • Officer
0 2011-01-07 0

DAVIE JOSEPH MD PHD

  • Director
0 2011-01-07 0

KEEGAN MITCHELL VICE-PRESIDENT

  • Officer
0 2011-01-07 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
No longer subject to file 2009-04-27 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL BIOTECH FUND LP

RA CAPITAL BIOTECH FUND II, L.P.

ALDRICH RICHARD

KOLCHINSKY PETER

  • 10% Owner
No longer subject to file 2008-04-15 0

CARTER STEPHEN

  • Director
0 2008-01-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CURIS INC CRIS 2021-05-10 22:15:04 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 21:45:02 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 21:15:02 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 20:45:03 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 20:15:03 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 19:45:03 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 19:15:03 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 18:45:03 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 18:15:03 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 17:45:02 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 17:15:03 UTC -0.7833 0.8333 550000
CURIS INC CRIS 2021-05-10 16:45:03 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 16:15:03 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 15:45:03 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 15:15:03 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 14:45:04 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 14:15:04 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 13:45:04 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 13:15:03 UTC -0.8359 0.8859 550000
CURIS INC CRIS 2021-05-10 12:45:02 UTC -0.8359 0.8859 550000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CRIS -5800.0 shares, $-65656.0 2021-03-31 N-PORT
Squarepoint Ops LLC Curis Inc 0.9% 2018-12-20 GERMANY

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Curis Inc 0.8% 2018-11-30 GERMANY
Squarepoint Ops LLC Curis Inc 0.78% 2018-11-07 GERMANY

Elevate your investments